" class="no-js "lang="en-US"> Shinichi Tamura - Medtech Alert
Wednesday, September 03, 2025
Shinichi Tamura

Shinichi Tamura

About Shinichi Tamura

Shinichi founded Sosei in June 1990 as a technology transfer company, having built up a wealth of experience during his years in the industry. He worked in various positions in Planning and Development at Fujisawa Pharmaceutical Co. Ltd and was later appointed Representative Director (CEO) of Genentech Limited (Genentech Inc’s Japan subsidiary). Shinichi has advised various companies including Genentech, GenPharm, Geron, IDEC, Pharmacyclics and Vernalis. He had been the CEO for 25 years before stepping down and became the Executive Chairman in 2016. 1 January 2019, Shinichi came back to the CEO aiming to realize the company’s vision to be a leading Japan-based biotech champion delivering innovative medicines for patients worldwide.

Related Story

Neurocrine Biosciences and Sosei Heptares Announce Collaboration to Develop Novel Muscarinic Receptor Agonists for Schizophrenia and Other Neuropsychiatric Disorders

November 22 2021

Neurocrine Biosciences, Inc. (Nasdaq: NBIX) and Sosei Group Corporation (“Sosei Heptares“; TSE: 4565) announce the signing […]